Crossmark

Focus on critical care nephrology

Published Online: 2019-07-11

Published Print: 2019-09

Authors

Darmon, Michaël https://orcid.org/0000-0003-4198-8038
Joannidis, Michael

Schetz, Miet
License Information

Text and Data Mining valid from 2019-07-11

Version of Record valid from 2019-07-11
More Information

Article History

Received: 15 May 2019

Accepted: 24 June 2019

First Online: 11 July 2019

Compliance with ethical standards

:

: Dr. Darmon reports having received consulting fees from Sanofi and Gilead-Kite, research support from Astute Medical and MSD, and speaker fees from MSD, Gilead-Kite and Astellas.Dr. Joannidis reports having received honoraria and research support from Baxter Healthcare Corp, AM-Pharma, CLS Behring, Fresenius, and Astute Medical and was a steering committee member of the STOP-AKI study.The other authors declare having no conflict of interest related to this manuscript.

Free to read: This content has been made available to all.

Document is current